Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial
Open Access
- 29 July 2015
- journal article
- research article
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 4 (3) , e93
Abstract
Background: Advanced glycation end products (AGEs) are formed during the processing, storage, and cooking of foods. As part of a western diet, AGEs are consumed in excess and impair glucose metabolism in patients with type 2 diabetes. In the absence of diabetes, AGE-mediated decreases in insulin sensitivity and signaling have been postulated. However, randomized studies to test this relationship in humans are limited. Objective: The primary aim of this trial is to determine whether dietary consumption of AGEs will decrease insulin sensitivity in healthy overweight adults. A secondary aim is to determine the effects of dietary AGEs on insulin secretion, circulating soluble receptor for AGEs (sRAGE), and inflammation markers. Methods: Overweight, but otherwise healthy, non-diabetic adults (N=20) aged 18-50 years old will complete a randomized cross-over design intervention study alternating low and high (4-fold increase) AGE diets (2-week duration). At baseline, participants will undergo a medical review including an intravenous glucose tolerance test (IVGTT), a hyperinsulinemic-euglycemic clamp, and anthropometric measures and questionnaires assessing diet, physical activity, and general wellness. Each test diet will be followed for 14 days, followed by a 4-week washout period before commencement of the second alternate dietary period. Energy, macronutrient, and AGE intake will be calculated for each dietary period. Additionally, the AGE content of foods used in the study will be measured by ultra performance liquid chromatography mass spectrometry. All measurements will be repeated at the beginning and end of each dietary period. Primary and secondary outcomes will be expressed as a change over the dietary period for insulin sensitivity, secretion, anthropometric parameters, sRAGE, and inflammation markers and compared by paired t test and analysis of variance (ANOVA). Results: The study will be completed in early 2016. Conclusion: The proposed trial will provide much needed clinical evidence on the impact of excess dietary AGE consumption on insulin sensitivity and will indicate whether lowering dietary AGE intake can improve insulin sensitivity and/or secretion, thereby decreasing risk for type 2 diabetes.Keywords
This publication has 34 references indexed in Scilit:
- Advanced Glycation End Products Are Direct Modulators of β-Cell FunctionDiabetes, 2011
- Targeted reduction of advanced glycation improves renal function in obesityKidney International, 2011
- Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 DiabetesDiabetes Care, 2011
- Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathyKidney International, 2010
- Advanced Glycation End Products Inhibit Glucose-Stimulated Insulin Secretion through Nitric Oxide-Dependent Inhibition of Cytochrome c Oxidase and Adenosine Triphosphate SynthesisEndocrinology, 2009
- Vitamin D Status and Its Relation to Age and Body Mass IndexHormone Research in Paediatrics, 2006
- Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptorProceedings of the National Academy of Sciences, 2006
- Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foodsAmino Acids, 2005
- Glycation in food and metabolic transit of dietary AGEs (advanced glycation end-products): studies on the urinary excretion of pyrralineBiochemical Society Transactions, 2003
- The Effect of Cooking upon the Blood Glucose Response to Ingested Carrots and PotatoesDiabetes Care, 1984